JKJudit Kálmán

Judit Kálmán

*This is an algorithmically generated author record based on publicly available information.

Judit Kálmán has a total of 11 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Modeling residual cholesteatoma growth rate: a meta-analysis of individual participant data

    by Borbála Körmendy, Judit Kálmán, Kata Illés, Péter Fehérvári, Alexander Schulze Wenning, Rita Nagy, Peter Hegyi, Francois Simon, Tamás Horváth

    Purpose: To create a model of residual cholesteatoma growth rate that can be used to estimate optimal timing of follow-up imaging. Methods: Following the recommendations of the PRISMA-IPD guideline and after registering our study protocol on PROSPERO (CRD42023465320), a systematic search was completed in September 2023 and updated in July 2024, conducted in PubMed, Web of Science, Embase, and Cochrane Library. Reference lists of the resulting articles were also searched for potential inclusions. Our search yielded 11,274 articles. Studies with patients of any age and sex diagnosed with residual cholesteatoma were included if data on cholesteatoma size at follow-up were available, collected from imaging results or through second-stage surgery. For statistical analysis, a Monte Carlo simulation approach was applied, and a baseline random-intercept mixed-effects model was fitted. Results: We included 11 articles reporting individual data from 163 patients. All but one of these articles proved to be high risk of bias. Our simulation models suggest that 95% of cholesteatomas reach or grow past the size of 3 millimetres (threshold for imaging) after 28–35 months and 95% of reach or grow past the size of 5 millimetres (threshold for intraoperative identification) after 47–58 months. Conclusion: Analyzing previously published data suggests that residual cholesteatoma may only be radiologically detectable on non-EPI DWI MRI after 28–35 months postoperatively in 95% of patients, indicating delayed follow-up for average risk patients compared to current clinical practice. However, this simulation model, based on retrospective data, aims to uncover growth patterns rather than posing as a new guideline.


  • Open Access

    Primary ossiculoplasties provide better hearing results than revisions: a retrospective cohort study

    by Judit Kálmán, Tamás Horváth, Kornél Dános, László Tamás, Gábor Polony

    Purpose: To evaluate the efficacy of ossicular chain reconstruction (OCR) in primary and revision surgeries, and to investigate the impact of the number of previous surgeries on hearing outcomes. Methods: Retrospective analysis of cases with OCR due to chronic otitis in a tertiary center between January 2018 and September 2021. Results: Altogether, 147 cases of ossicle involvement were assessed. In 91.83% (n = 135) OCR was performed, 96.26% of them with titanium TORP/PORP (n = 130), two cases with autologous prosthesis and three with piston. Mean follow-up was 8.8 months. The ABG significantly improved in the total group (TORP/PORP) from a mean (SD) of 30.94 (15.55) to 19.76 (13.36) dB (p < 0.0001) with 60.86% success. The best results were achieved in primary OCR with PORP implantation without cholesteatoma (89.47%). Primary cases have a significantly higher success rate in contrary to revision surgeries (72.27%, vs. 52.00%, p = 0.032). The only relevant predictive factor proved to be the fact of revision (p = 0.029). A statistically significant correlation between the number of previous surgeries and hearing results could not be proved. There was no difference in hearing outcomes between patients with only one or more than one previous surgeries in the revision groups. Neither the presence of cholesteatoma, nor the type of OCR (TOPR/PORP) and the indication of revision had an impact on postoperative ABG. Conclusions: Titanium prostheses are effective in OCR both in primary and revision cases. It is not the number of previous surgeries, but the fact of revision that influences postoperative hearing results.